Pharmaceutical Products
Description
orteronel(TAK-700)was selected as a candidate for clinical evaluation. orteronel(TAK-700) is currently in phase III clinical trials for the treatment of castration-resistant prostate cancer.
http://www.chemscene.com/Orteronel.html
Read More
ChemScene, LLC
ChemScene Pharmaceutical chemical
Address: 11 Deer Park Drive, Suite 102A, Monmouth Junction, NJ 08852,
jersey, new jersey
United States, 07097
Tel: 732-484-9848
Fax: